Annual Non Current Assets
$75.06 M
+$1.52 M+2.06%
December 31, 2023
Summary
- As of February 7, 2025, ADAP annual long term assets is $75.06 million, with the most recent change of +$1.52 million (+2.06%) on December 31, 2023.
- During the last 3 years, ADAP annual non current assets has risen by +$22.07 million (+41.66%).
- ADAP annual non current assets is now at all-time high.
Performance
ADAP Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$73.22 M
+$5.29 M+7.79%
September 30, 2024
Summary
- As of February 7, 2025, ADAP quarterly long term assets is $73.22 million, with the most recent change of +$5.29 million (+7.79%) on September 30, 2024.
- Over the past year, ADAP quarterly non current assets has increased by +$2.12 million (+2.97%).
- ADAP quarterly non current assets is now -9.84% below its all-time high of $81.21 million, reached on June 30, 2023.
Performance
ADAP Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ADAP Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.1% | +3.0% |
| 3 y3 years | +41.7% | +38.0% |
| 5 y5 years | +64.5% | +19.5% |
ADAP Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.8% | -9.8% | +35.4% |
| 5 y | 5-year | at high | +41.7% | -9.8% | +40.0% |
| alltime | all time | at high | >+9999.0% | -9.8% | +5017.9% |
Adaptimmune Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $73.22 M(+7.8%) |
| Jun 2024 | - | $67.93 M(-4.5%) |
| Mar 2024 | - | $71.11 M(-5.3%) |
| Dec 2023 | $207.55 M(-18.7%) | $75.06 M(-2.9%) |
| Sep 2023 | - | $77.27 M(-4.9%) |
| Jun 2023 | - | $81.21 M(+9.3%) |
| Mar 2023 | - | $74.33 M(+1.1%) |
| Dec 2022 | $255.37 M(-38.5%) | $73.55 M(+8.1%) |
| Sep 2022 | - | $68.06 M(+1.4%) |
| Jun 2022 | - | $67.11 M(+11.2%) |
| Mar 2022 | - | $60.34 M(+11.6%) |
| Dec 2021 | $415.46 M(+4.3%) | $54.09 M(+1.9%) |
| Sep 2021 | - | $53.08 M(+1.2%) |
| Jun 2021 | - | $52.45 M(+0.3%) |
| Mar 2021 | - | $52.29 M(-1.3%) |
| Dec 2020 | $398.15 M(+230.4%) | $52.99 M(+1.3%) |
| Sep 2020 | - | $52.29 M(-3.4%) |
| Jun 2020 | - | $54.11 M(-5.9%) |
| Mar 2020 | - | $57.48 M(-5.9%) |
| Dec 2019 | $120.49 M | $61.05 M(-0.4%) |
| Sep 2019 | - | $61.28 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $64.39 M(-8.2%) |
| Mar 2019 | - | $70.14 M(+53.7%) |
| Dec 2018 | $231.09 M(+0.4%) | $45.64 M(-5.0%) |
| Sep 2018 | - | $48.02 M(-3.3%) |
| Jun 2018 | - | $49.65 M(-3.4%) |
| Mar 2018 | - | $51.41 M(+0.9%) |
| Dec 2017 | $230.18 M(+15.8%) | $50.96 M(+7.4%) |
| Sep 2017 | - | $47.47 M(+2.0%) |
| Jun 2017 | - | $46.53 M(+8.1%) |
| Mar 2017 | - | $43.05 M(+20.4%) |
| Dec 2016 | $198.75 M(-24.4%) | $35.76 M(+54.8%) |
| Sep 2016 | - | $23.10 M(+8.1%) |
| Jun 2016 | - | $21.38 M(-7.0%) |
| Mar 2016 | - | $23.00 M(+55.9%) |
| Dec 2015 | $263.05 M(-10.9%) | - |
| Sep 2015 | - | $14.75 M(+418.3%) |
| Jun 2015 | $295.08 M(+445.6%) | - |
| Dec 2014 | - | $2.85 M(+99.0%) |
| Jun 2014 | $54.09 M(+3275.6%) | $1.43 M |
| Jun 2013 | $1.60 M(-58.6%) | - |
| Jun 2012 | $3.87 M | - |
FAQ
- What is Adaptimmune Therapeutics annual long term assets?
- What is the all time high annual non current assets for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual non current assets year-on-year change?
- What is Adaptimmune Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly non current assets year-on-year change?
What is Adaptimmune Therapeutics annual long term assets?
The current annual non current assets of ADAP is $75.06 M
What is the all time high annual non current assets for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual long term assets is $75.06 M
What is Adaptimmune Therapeutics annual non current assets year-on-year change?
Over the past year, ADAP annual long term assets has changed by +$1.52 M (+2.06%)
What is Adaptimmune Therapeutics quarterly long term assets?
The current quarterly non current assets of ADAP is $73.22 M
What is the all time high quarterly non current assets for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly long term assets is $81.21 M
What is Adaptimmune Therapeutics quarterly non current assets year-on-year change?
Over the past year, ADAP quarterly long term assets has changed by +$2.12 M (+2.97%)